LMP Capital and Income Fund Inc. (SCD)
Stock analysis · NYSE · Financial Services · Asset Management - Income
LMP Capital and Income Fund Inc. (SCD) is a publicly traded company in the Financial Services sector. Latest price: $15.06. Market cap $344.97M. Trailing PE 5.36. Dividend yield 9.56%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About LMP Capital and Income Fund Inc.
The LMP Capital and Income Fund Inc. operates as a closed-end balanced mutual fund, primarily overseen by Legg Mason Partners Fund Advisor, LLC. Additional management responsibilities are shared with Clearbridge Investments, LLC, Western Asset Management Company Limited, and Western Asset Management Company. Its investment mandate extends globally, encompassing both public equity and fixed-income securities from businesses spanning various sectors. Key holdings include shares of large-capitalization firms, corporate bonds and notes of intermediate maturity with a minimum A- rating, both energy and non-energy master limited partnerships (MLPs), and real estate investment trusts (REITs). Portfolio construction is heavily influenced by a rigorous analysis of economic, market, and political landscapes, as well as fiscal and monetary policies, alongside thorough security valuation. Its performance is measured against two standard benchmarks: the U.S. Aggregate Index and the S&P 500 Index. Established in the United States on November 12, 2003, it was previously recognized as the Salomon Brothers Capital and Income Fund Inc.
Valuation
| P/E (TTM) | 5.36× |
|---|---|
| P/S (TTM) | 29.69× |
| P/B | 0.87× |
| PEG | 0.02× |
| P/FCF (TTM) | 47.16× |
| EV / EBITDA | 6.57× |
| EV / Sales | 38.65× |
| Earnings Yield | 18.64% |
| Free Cash Flow Yield | 2.12% |
| Dividend Yield | 9.56% |
Fundamentals
| Enterprise Value | $448.99M |
|---|---|
| Revenue (TTM) | $11.62M |
| Net Income (TTM) | $64.31M |
| Free Cash Flow (TTM) | $11.40M |
| Net Debt | $104.02M |
| Working Capital | -$93.90M |
| Gross Margin | 97.54% |
| Operating Margin | 306.39% |
| Net Margin | 553.49% |
| Return on Equity | 16.62% |
| Return on Invested Capital | 7.08% |
Peers
Recent News
- SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Seps…
- FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients wit…
- Roche launches newborn screening test for three severe genetic conditions
- SCD: High Midstream/Low Bond Exposure Is A Good Combination
- 10 Best CEFs This Month: Average Yield Of Near 10% (August 2026)
Related
Browse more tickers: sitemap